Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kopper

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Orvosi Hetilap|October 11, 1992
[Theoretical possibility of using gene therapy in malignant diseases]L Kopper
Pathology, Research and Practice|May 1, 1985
What's new in macrophage-tumor cell interaction?L Kopper, K Lapis
Orvosi Hetilap|July 21, 1999
[Cell death and tumor formation]L Kopper, R Mihalik
Orvosi Hetilap|February 26, 1978
[Xenotransplantation of human malignant tumors]L Kopper, K Lapis
Anticancer Research|April 13, 2001
Syndecan-1 expression in different soft tissue tumoursZ Orosz, L Kopper
Magyar Onkologia|June 7, 2002
[The role of syndecans in lymphoid systems]A Sebestyén, L Kopper
Leukemia & Lymphoma|June 1, 2000
Syndecans and the lymphoid systemL Kopper, A Sebestyén
Orvosi Hetilap|July 12, 1992
[Pathology--on a molecular level (determination of nucleic acids from fixed embedded samples)]L Kopper, I Kovalszky
In Vivo (Athens, Greece)|November 1, 1994
Antisense tumor therapy (a dream under construction)L Kopper, I Kovalszky
Cancer Research|October 1, 1975
The therapeutic response of three human tumor lines maintained in immune-suppressed miceL Kopper, G G Steel
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Orvosi Hetilap|October 11, 1992
[Theoretical possibility of using gene therapy in malignant diseases]L Kopper
Pathology, Research and Practice|May 1, 1985
What's new in macrophage-tumor cell interaction?L Kopper, K Lapis
Orvosi Hetilap|July 21, 1999
[Cell death and tumor formation]L Kopper, R Mihalik
Orvosi Hetilap|February 26, 1978
[Xenotransplantation of human malignant tumors]L Kopper, K Lapis
Anticancer Research|April 13, 2001
Syndecan-1 expression in different soft tissue tumoursZ Orosz, L Kopper
Magyar Onkologia|June 7, 2002
[The role of syndecans in lymphoid systems]A Sebestyén, L Kopper
Leukemia & Lymphoma|June 1, 2000
Syndecans and the lymphoid systemL Kopper, A Sebestyén
Orvosi Hetilap|July 12, 1992
[Pathology--on a molecular level (determination of nucleic acids from fixed embedded samples)]L Kopper, I Kovalszky
In Vivo (Athens, Greece)|November 1, 1994
Antisense tumor therapy (a dream under construction)L Kopper, I Kovalszky
Cancer Research|October 1, 1975
The therapeutic response of three human tumor lines maintained in immune-suppressed miceL Kopper, G G Steel
Pageof 11